Taylor Soon-Sutton, MD
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,024 of the $3,479 with a category attached, or 86.9%. 27 manufacturers reported payments, led by Boston Scientific at 25.0% of the total. Reporting peaked in 2024 at $877 and has fallen 55.6% since, to $389 in 2025.
Across 63 payments — averaging $55.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$869
- Teleflex LLC$387
- Coloplast$316
- Intuitive Surgical$275
- Astellas Pharma US Inc$202
- Laborie Medical Technologies Corp.$149
- plus $1K from 21 others
What the payments were for
- Travel & lodging$2758%
- Food & beverage$3,02487%
- Education$1805%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $869 |
| Teleflex LLC | 6 | $387 |
| Coloplast | 3 | $316 |
| Intuitive Surgical | 2 | $275 |
| Astellas Pharma US Inc | 3 | $202 |
| Laborie Medical Technologies Corp. | 2 | $149 |
| Calyxo, Inc. | 1 | $146 |
| Cook Medical LLC | 4 | $140 |
| AbbVie | 6 | $124 |
| KARL Storz Endoscopy-america | 2 | $122 |
| Janssen Scientific Affairs, LLC | 2 | $121 |
| Bayer | 2 | $102 |
| Olympus America Inc. | 1 | $89 |
| Innovation Technologies Inc | 1 | $84 |
| Pfizer | 3 | $59 |
| Photocure Inc | 1 | $33 |
| Procept Biorobotics Corporation | 1 | $33 |
| Dendreon Pharmaceuticals LLC | 1 | $32 |
| Merck | 2 | $31 |
| Neotract Inc. | 1 | $30 |
| Urogen Pharma, Inc. | 1 | $27 |
| Accord Healthcare, Inc. | 1 | $25 |
| Endo USA, Inc. | 1 | $22 |
| Verity Pharmaceuticals Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $17 |
| 180 Medical, Inc. | 1 | $13 |
| Melinta Therapeutics, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$256
- TITAN$238
- AdVance XP$147
- CVAC Aspiration System$146
- UroLift$140
- LithoVue$140
- GREENLIGHT$130
- Tria Firm$100
How this compares
$3,479 in reported general payments places this provider in the 55th percentile of 79 urology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alfuzosin Hcl ErAlfuzosin Hcl | 80 | $1,877 |
| Estradiol | 33 | $1,841 |
| Tamsulosin Hcl | 89 | $1,065 |
| Finasteride | 78 | $1,045 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $133 |
Paid to pharmacies, not to this prescriber.
Other urology in Omaha
- John BishayOmaha$138K
- Rebecca McCreryOmaha$71K
- Judson DaviesOmaha$67K
- Stefanie BolteOmaha$59K
- Michael FeloneyOmaha$29K
- Andrew TrainerOmaha$12K
- Stephen LeslieOmaha$12K
- Jon MortonOmaha$11K
- Brett HillOmaha$11K
- John HorganOmaha$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.